ALOPM — Oncodesign Precision Medicine Opm SA Cashflow Statement
0.000.00%
- €8.34m
- €12.42m
- €0.21m
- 28
- 84
- 25
- 39
Annual cashflow statement for Oncodesign Precision Medicine Opm SA, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | |||||
Standards: | — | — | — | — | — |
Status: | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |